杏林製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2021/05/20 | 1,753 | 1,765 | 1,742 | 1,742 | -16 | -0.9% | 91,900 |
2021/05/19 | 1,734 | 1,758 | 1,734 | 1,758 | +13 | +0.7% | 144,900 |
2021/05/18 | 1,729 | 1,745 | 1,721 | 1,745 | +16 | +0.9% | 147,000 |
2021/05/17 | 1,726 | 1,749 | 1,722 | 1,729 | -1 | -0.1% | 188,800 |
2021/05/14 | 1,700 | 1,739 | 1,691 | 1,730 | +40 | +2.4% | 222,400 |
2021/05/13 | 1,705 | 1,713 | 1,689 | 1,690 | -8 | -0.5% | 227,100 |
2021/05/12 | 1,830 | 1,834 | 1,693 | 1,698 | -184 | -9.8% | 657,700 |
2021/05/11 | 1,908 | 1,912 | 1,882 | 1,882 | -26 | -1.4% | 176,400 |
2021/05/10 | 1,916 | 1,921 | 1,905 | 1,908 | -28 | -1.4% | 159,000 |
2021/05/07 | 1,942 | 1,952 | 1,932 | 1,936 | +7 | +0.4% | 75,800 |
2021/05/06 | 1,915 | 1,970 | 1,915 | 1,929 | +16 | +0.8% | 258,700 |
2021/04/30 | 1,912 | 1,937 | 1,906 | 1,913 | -3 | -0.2% | 161,600 |
2021/04/28 | 1,900 | 1,925 | 1,897 | 1,916 | +7 | +0.4% | 130,600 |
2021/04/27 | 1,904 | 1,920 | 1,899 | 1,909 | +2 | +0.1% | 141,100 |
2021/04/26 | 1,899 | 1,908 | 1,898 | 1,907 | -13 | -0.7% | 146,500 |
2021/04/23 | 1,920 | 1,926 | 1,914 | 1,920 | -6 | -0.3% | 132,100 |
2021/04/22 | 1,911 | 1,926 | 1,910 | 1,926 | +26 | +1.4% | 173,400 |
2021/04/21 | 1,890 | 1,903 | 1,881 | 1,900 | +5 | +0.3% | 183,100 |
2021/04/20 | 1,898 | 1,906 | 1,891 | 1,895 | -16 | -0.8% | 96,500 |
2021/04/19 | 1,919 | 1,921 | 1,911 | 1,911 | -3 | -0.2% | 63,400 |
2021/04/16 | 1,911 | 1,916 | 1,900 | 1,914 | +7 | +0.4% | 73,300 |
2021/04/15 | 1,906 | 1,914 | 1,902 | 1,907 | +4 | +0.2% | 75,700 |
2021/04/14 | 1,908 | 1,912 | 1,892 | 1,903 | -7 | -0.4% | 135,200 |
2021/04/13 | 1,918 | 1,923 | 1,910 | 1,910 | +2 | +0.1% | 93,800 |
2021/04/12 | 1,900 | 1,912 | 1,897 | 1,908 | +13 | +0.7% | 118,000 |
2021/04/09 | 1,905 | 1,913 | 1,895 | 1,895 | +1 | +0.1% | 119,900 |
2021/04/08 | 1,903 | 1,907 | 1,892 | 1,894 | -22 | -1.1% | 201,200 |
2021/04/07 | 1,911 | 1,923 | 1,906 | 1,916 | -4 | -0.2% | 137,800 |
2021/04/06 | 1,935 | 1,940 | 1,916 | 1,920 | -15 | -0.8% | 140,200 |
2021/04/05 | 1,939 | 1,942 | 1,927 | 1,935 | +10 | +0.5% | 65,100 |
2021/04/02 | 1,940 | 1,943 | 1,922 | 1,925 | -2 | -0.1% | 90,800 |
2021/04/01 | 1,951 | 1,958 | 1,924 | 1,927 | -1 | -0.1% | 77,700 |
2021/03/31 | 1,932 | 1,944 | 1,924 | 1,928 | -24 | -1.2% | 184,400 |
2021/03/30 | 1,965 | 1,965 | 1,939 | 1,952 | -61 | -3% | 214,700 |
2021/03/29 | 2,030 | 2,042 | 1,991 | 2,013 | +1 | ±0% | 287,700 |
2021/03/26 | 2,000 | 2,026 | 1,998 | 2,012 | +21 | +1.1% | 148,500 |
2021/03/25 | 2,000 | 2,004 | 1,983 | 1,991 | +14 | +0.7% | 138,300 |
2021/03/24 | 2,017 | 2,027 | 1,977 | 1,977 | -63 | -3.1% | 203,300 |
2021/03/23 | 2,075 | 2,075 | 2,040 | 2,040 | -31 | -1.5% | 167,900 |
2021/03/22 | 2,052 | 2,073 | 2,050 | 2,071 | +28 | +1.4% | 132,000 |
2021/03/19 | 2,049 | 2,062 | 2,030 | 2,043 | +17 | +0.8% | 225,000 |
2021/03/18 | 2,021 | 2,040 | 2,005 | 2,026 | -16 | -0.8% | 165,100 |
2021/03/17 | 2,020 | 2,042 | 2,014 | 2,042 | +23 | +1.1% | 152,000 |
2021/03/16 | 1,990 | 2,025 | 1,985 | 2,019 | +33 | +1.7% | 228,400 |
2021/03/15 | 1,973 | 1,986 | 1,967 | 1,986 | +19 | +1% | 133,700 |
2021/03/12 | 1,963 | 1,973 | 1,951 | 1,967 | -6 | -0.3% | 146,300 |
2021/03/11 | 1,975 | 1,985 | 1,966 | 1,973 | +2 | +0.1% | 105,200 |
2021/03/10 | 1,977 | 1,977 | 1,962 | 1,971 | -10 | -0.5% | 104,800 |
2021/03/09 | 1,953 | 1,988 | 1,946 | 1,981 | +40 | +2.1% | 186,400 |
2021/03/08 | 1,945 | 1,948 | 1,930 | 1,941 | +5 | +0.3% | 114,400 |
951~
1000
件表示中 / 3674件
類似銘柄と比較する
現在ご覧いただいている「杏林製薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
杏林製薬 | 136,500円 | +3.2% | +4.5% | 3.81% | 15.68倍 | 0.60倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
持田薬 | 290,300円 | +3.0% | +27.5% | 2.76% | 18.38倍 | 0.80倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
サンバイオ | 138,800円 | - | - | 0.00% | - | 64.29倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
栄研化 | 201,200円 | +0.4% | -8.4% | 2.63% | 25.83倍 | 1.46倍 |
|
臨床検査薬大手。便潜血検査試薬(FIT)はシェア7割。尿検査(ウロ)、遺伝子検査も育成 |
ジーエヌアイ | 149,000円 | +21.7% | +999.9% | 0.00% | 6.20倍 | 2.05倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
市場注目の銘柄
チャート関連のコラム